Conformity with stringent new EU regulations for medical devices confirmed Allows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countries Major ...

The US FDA has granted 510(k) clearance, expanding the label of BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) ...

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countriesMajor m ...

Researchers investigated the impact of transcranial electrical stimulation interventions on treatment of depressive symptoms.

While the FDA has approved digital mental health solutions in recent years, including apps with solutions involving cognitive behavioral therapy (CBT), the agency has yet to clear mental health tools ...

BrainsWay announced today that the FDA granted a label expansion for its deep transcranial magnetic stimulation (Deep TMS) ...

The FDA has granted 510(k) clearance and a label expansion for a transcranial magnetic stimulation device to treat patients ...

The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.

Deep TMS™ becomes first and only TMS device cleared in treatment of patients aged 15 to 86 suffering from depression. BURLINGTON, Mass. and JERUSALEM, Israel, (GLO ...

The medical device industry faces growing pressure to align U.S. and EU regulations, with the EU’s Medical Device Regulation ...

Risk factors for suicide attempt (SA) and suicide may have overlapping phenotypes that are related yet have distinct outcomes, which can inform screening practices, risk prediction, and prevention, ...

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...